Navigation Links
Despite Employee Strike, Davis Vision Lab Continues to Fulfill Eyeglass Orders Without Service Interruption
Date:2/2/2012

NEWTOWN SQUARE, Pa., Feb. 2, 2012 /PRNewswire/ -- On Jan. 23, IUE/CWA Local 81408, the optical workers union that represents associates at Davis Vision's Newtown Square eyeglass manufacturing facility, went on strike. This move has not been endorsed by the international union (IUE/CWA). Although 115 employees are covered under the bargaining unit contract, 32 have continued to work.

According to company officials, each day, additional employees have crossed the picket line and returned to work. Importantly, pre-strike production and quality levels have not been impacted since the walkout began.

"Together with the management team, these dedicated employees continue to provide the service expected by our clients who depend on us for their eyeglasses," said Davis Vision President Steve Holden. "We are fortunate to have the full capacity of our HVHC lab system available to ensure our production and quality standards are maintained and our current and future orders are filled. The processing of orders has been seamless and our members have not been affected by the strike."

Holden also noted that more employees are realizing their union leadership has not fully disclosed the details of the Davis Vision proposed new contract, including the value of the wages, benefits and employment opportunities provided by the company. For example, under the expired contract, employees at the Newtown Square lab earned on average just under $1,700 in total bi-weekly earnings, including incentives.

The proposed contract, which the union has turned down, increases employee earning potential to more than $1,800 on average bi-weekly including an incentive of $9.50 per hour if goals are met.

Also in the proposed contract, Davis Vision has increased the weight of the "quality" component of daily goals at the lab, providing more balance in its employee incentive offering.

During the strike, Davis Vision has maintained employee health care coverage on
'/>"/>

SOURCE Davis Vision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
2. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
5. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
6. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
7. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
10. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
11. Despite Recessionary Pressures, Patient and Surgeon Demand Will Drive the Joint Arthroplasty and Fixation Bone Cement Market by 7% Annually Through 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... blood ... flow, muscle oxygen supply, HOBOKEN, N.J., Oct. 17 ... reveals Pycnogenol(R),(pic-noj-en-all), an antioxidant plant extract from the bark of the ... which leads to an increase in blood flow and oxygen supply,to ...
... Joint Venture Between Bristol-Myers Squibb, Company ... in HIV Treatment -, PRINCETON, N.J. and ... Company (NYSE: BMY ) and Gilead Sciences, ... Canada has approved ATRIPLA(R),(efavirenz 600 mg/emtricitabine 200 mg/tenofovir ...
Other Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... Inc. (NYSE: CSV ) today announced results for the first quarter ended March 31, 2009. Highlights from continuing operations for ... in millions, except per share amounts) , , ... Q1, ... Change, ...
... Inc.,s parent company, Team Finance LLC (the "Company"), today announced ... less provision for uncollectibles ("revenue less provision") in the first ... million in the first quarter of 2008. Same contract ... million from $305.5 million in the same period a year ...
... of these meds with their doctor, cardiac group says ... takes the clot-preventing drug Plavix after receiving a stent ... medications called proton pump inhibitors (PPIs), if possible, a ... blockbuster acid reflux medications such as Nexium, Prevacid and ...
... Contributions emphasize need for improved mental health services ... The Regence Foundation announced today it awarded $390,000 ... Idaho, Oregon, Utah and Washington. Five of the ... organizations nominated by Regence employees as part of ...
... age of those hospitalized in U.S. is 15, CDC says ... majority of U.S. cases continue to be mild, those who ... atypically young, health officials said Wednesday. , In fact, the ... which is younger than occurs in regular seasonal flu, U.S. ...
... The following was released today by Americans for ... National Institute for Occupational Safety and Health (NIOSH) ... dangerous levels of secondhand smoke at work. NIOSH recommends ... casinos is safe for workers to breathe. In 2005, ...
Other Medicine News:Health News:Carriage Services Announces First Quarter 2009 Results 2Health News:Carriage Services Announces First Quarter 2009 Results 3Health News:Carriage Services Announces First Quarter 2009 Results 4Health News:Carriage Services Announces First Quarter 2009 Results 5Health News:Carriage Services Announces First Quarter 2009 Results 6Health News:Carriage Services Announces First Quarter 2009 Results 7Health News:Carriage Services Announces First Quarter 2009 Results 8Health News:Carriage Services Announces First Quarter 2009 Results 9Health News:Carriage Services Announces First Quarter 2009 Results 10Health News:Carriage Services Announces First Quarter 2009 Results 11Health News:Carriage Services Announces First Quarter 2009 Results 12Health News:Carriage Services Announces First Quarter 2009 Results 13Health News:Carriage Services Announces First Quarter 2009 Results 14Health News:Carriage Services Announces First Quarter 2009 Results 15Health News:Team Finance LLC Announces First Quarter 2009 Results 2Health News:Team Finance LLC Announces First Quarter 2009 Results 3Health News:Team Finance LLC Announces First Quarter 2009 Results 4Health News:Team Finance LLC Announces First Quarter 2009 Results 5Health News:Team Finance LLC Announces First Quarter 2009 Results 6Health News:Team Finance LLC Announces First Quarter 2009 Results 7Health News:Team Finance LLC Announces First Quarter 2009 Results 8Health News:Plavix, Heartburn Drugs May Be Risky Combination 2Health News:Plavix, Heartburn Drugs May Be Risky Combination 3Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 2Health News:Regence Foundation Grants $390,000 to Improve Health Care Safety Net 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 2Health News:Younger Age of Severe Swine Flu Cases Worries Experts 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 4Health News:Younger Age of Severe Swine Flu Cases Worries Experts 5Health News:Younger Age of Severe Swine Flu Cases Worries Experts 6Health News:Younger Age of Severe Swine Flu Cases Worries Experts 7Health News:Younger Age of Severe Swine Flu Cases Worries Experts 8Health News:Younger Age of Severe Swine Flu Cases Worries Experts 9Health News:Younger Age of Severe Swine Flu Cases Worries Experts 10Health News:Younger Age of Severe Swine Flu Cases Worries Experts 11
Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single...
Stylet - Infant Stainless Steel, Flexible, Non-Sterile, Latex Free, With stop, Suitable for tubes 2.0 mm I.D. or larger....
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
Medicine Products: